20260624_OMRE_Penyampaian Bukti Iklan_32103975_lamp2.pdf

    President Commissioner            :   Mr. Husni Ali
    Vice President Commissioner       :   Mr. Dr. Syahrul Effendi, SH, MM
    Independent Commissioner          :   Mr. Drs. H. Lutfi Dahlan
    Independent Commissioner          :   Mr. Drs. Ris Sutarto
    Independent Commissioner          :   Mr. Gatot Subroto

C. The Meeting was attended and represented by 2.758.517.222 shares with valid voting
   rights or 93,66% of the Company’s total issued shares.

D. The Meeting had provided an opportunity for the shareholders to raise questions and/or
   provide opinion related to the agenda of the Meeting, but in the Meeting there were no
   shareholders or their proxies who asked questions and or gave opinions regarding the
   agenda Meeting.

E. Decision Making Mechanism of the Meeting :
   Resolutions of the Meeting were conducted openly and carried out by way of amicable
   discussion. In the event that the amicable agreement was not reached, decision
   making was adopted by way of voting.

F. Voting results for every agenda item of the Meeting :

        Agenda                 Approve              Not Approve             Abstain
          1                 2.758.517.222                0                    0
                                100%
            2               2.758.517.222                  0                    0
                                100%
            3               2.758.517.222                  0                    0
                                100%


G. Resolutions of the Meeting

   Agenda Item 1:
   The Meeting unanimously by way of amicable discussion resolved :

   For point a on the Agenda Item 1 of the Meeting :
   1. To accept the Company’s Annual Report for the book year 2025.
   2. To approve the Company’s Financial Statements for the book year 2025,
        which has been audited by the Public Accounting Firm “Liana Ramon Xenia &
        Rekan”, wherein Mrs. Caroline Ardianti Indrianto as Partner has been appointed
        as the Company's Independent Public Accountant, as evident in his Report
        Number 00111/2.1460/AU.1/03/1798-1/1/III/2026, March 30, 2026, with the
        opinion “Fairly Unmodified”.
   3. To accept the Board of Directors’ Report and to approve the Board of
        Commissioners’ Supervisory Duties Report for the book year 2025.
   4. Upon the approval of the Annual Report and the Company's Annual Financial
        Statements for the 2025 financial year, and pursuant to Article 17 paragraph 3 of
        the Company's Articles of Association, to grant a full release and discharge (acquit
        et de charge) to all members of the Board of Directors for their management
        actions and to all members of the Board of Commissioners for their supervisory
        actions performed during the 2025 financial year, insofar as such actions are
        reflected in the Annual Report and Annual Financial Statements of the Company
        for the 2025 financial year, except for any acts of fraud, embezzlement, or other
        criminal offenses.

For point b on the Agenda Item 1 of the Meeting :
   -To approve not to distribute dividend to the Company’s shareholders, as the
   Company suffer losses for the book year 2025.

Agenda Item 2:
The Meeting unanimously by way of amicable discussion resolved :

To authorize the Company's Board of Commissioners :
 1. Based on the recommendation of the Company’s Audit Committee, to appoint an
    Independent Public Accountant to audit the Consolidated Statements Of Financial
    Position, Consolidated Statements Of Profit Or Loss And Other Comprehensive
    Income and other parts of the Company's Financial Statements for the book year
    ended on December 31, 2026; and
 2. To determine the honorarium for the Independent Public Accountant and other
    requirements with respect to its appointment.

Agenda Item 3:
The Meeting unanimously by way of amicable discussion resolved :

For point a on the Agenda Item 3 of the Meeting :
1. In connection with the expiration of the current terms of office of the members of
     the Board of Directors and the Board of Commissioners of the Company at the
     close of the Meeting, to reappoint the members of the Board of Directors and the
     Board of Commissioners of the Company for a term commencing from the closing
     of the Meeting until the closing of the Company's second Annual General Meeting
     of Shareholders, namely in 2028, without prejudice to the right of the Company's
     General Meeting of Shareholders to dismiss them at any time in accordance with
     Article 10 paragraph 2 and Article 13 paragraph 3 of the Company's Articles of
     Association, with the following composition :

       Board of Directors :
       President Director                 :   Mrs. Laura Rahardja, SE
       Vice President Director            :   Mr. Sriyanto
       Director                           :   Mr. Ir. Njudarsono Yusetijo
       Director                           :   Mr. Drs. Syamsuddin Lologau
       Director                           :   Mr. Chandraja Harita

       Board of Commissioners :
       President Commissioner             :   Mr. Husni Ali
       Vice President Commissioner        :   Mr. Dr. Syahrul Effendi, SH, MM.
       Commissioner                       :   Mr. Drs. Ris Sutarto
       Commissioner                       :   Mr. Gatot Subroto
       Commissioner                       :   Mr. Chiu Man Sing

2.   To comply with the provisions of Article 13 paragraph 1 of the Company's Articles
     of Association, to designate Mr. Drs. Ris Sutarto and Mr. Gatot Subroto as the
     Independent Commissioners of the Company.

3.   To grant authority to the Board of Directors of the Company, with the right of
     substitution, to restate the resolutions adopted under this agenda item in
     a separate Notarial Deed and thereafter notify and/or register such resolutions with
     the Minister of Law of the Republic of Indonesia and/or other competent
     authorities, and for such purpose to take all actions required under the prevailing
     laws and regulations.

For point b on the Agenda Item 3 of the Meeting :
1. In accordance with the provisions of Article 11 paragraph 7 of the Company's
     Articles of Association, to delegate authority to the Board of Directors of the
     Company, through a Board of Directors Meeting, on behalf of the General Meeting
     of Shareholders, to determine the duties and authorities of each member of the
     Board of Directors of the Company.
2. In accordance with the provisions of Article 10 paragraph 3 and Article 13
     paragraph 4 of the Company's Articles of Association, to approve the following :
     a. to authorize the Company's Board of Commissioners to determine the amount
         of salary and other allowances for the Company's members of the Board of
         Directors.
     b. to determine the honorarium and other allowances for the members of the
         Company's Board of Commissioners, adjusted by a maximum increase of 10%
         (ten percent) above the amount of honorarium and other allowances received
         by each member of the Company's Board of Commissioners for the previous
         financial year.
     c. to authorize the Company's Board of Commissioners to determine the
         distribution of the honorarium and other allowances to each Company's
         members of the Board of Commissioners.


                               Jakarta, June 24, 2026
                          The Company's Board of Directors